Metraipolis › archive › dc_2b0d2a16cccb

Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review — Europe PMC PMID:42824982

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42824982
DOI
10.3389/fmed.2026.1928491
License (as archived)
solo-consultazione
Archived
2026-10-09T06:17:46.944Z
SHA-256 of the archived text
0ae6a8b27f5ed719f8eacfb5afc1902a6d12dfe4b5b0970899daca7eea5d7750
Stable URL of this page
https://metraipolis.com/documento/dc_2b0d2a16cccb

How to cite

Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review — Europe PMC PMID:42824982 — Europe PMC (en), https://europepmc.org/article/MED/42824982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b0d2a16cccb (Metraipolis archive dc_2b0d2a16cccb, sha256 0ae6a8b27f5ed719f8eacfb5afc1902a6d12dfe4b5b0970899daca7eea5d7750)
BibTeX
@misc{dc2b0d2a16cccb,
  title = {Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review — Europe PMC PMID:42824982},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42824982},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b0d2a16cccb; sha256 0ae6a8b27f5ed719f8eacfb5afc1902a6d12dfe4b5b0970899daca7eea5d7750},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824982. Agents can read the archived copy with the MCP tool read_document.